Home » Topics » Regulatory

Regulatory
RSS

Roberts' Agrylin approved by FDA

March 18, 1997

ProCyte's hair transplant wound dressing approved by FDA

March 17, 1997

FDA approves Viracept for adult and pediatric use

March 17, 1997

First approval for Zomig; antimigraine agents in development

March 14, 1997

First approval for naratriptan

March 12, 1997

Pfizer initiates clinical trial in panic disorder

March 12, 1997

Teva receives tentative approval for ketorolac tromethamine

March 7, 1997

RAS inhibitors reduce mortality in a model of cerebral ischemia

March 5, 1997

Matrix selects distribution partner for Italy

March 5, 1997

Imiquimod for postviral asthma-like syndrome

Feb. 25, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.